New Skin Care Based on Mannatech’s Pioneering Work in Glycobiology
COPPELL, Texas--(BUSINESS WIRE)--Nov. 12, 2013--
Mannatech®,
Incorporated (NASDAQ: MTEX),
the founder of the Mission
5 MillionSM social entrepreneurial movement and leading
innovator of naturally-sourced supplements based on Real
Food Technology® solutions, launched Ūth
Advanced Skin Matrix Rejuvenation Crème, a revolutionary new skin
care product based on their pioneering work in the science of
glycobiology.
Ūth, pronounced “youth,” symbolizes ageless beauty whose time
has come. The official launch of the skin care product took place at
Mannatech’s M5M℠
Leadership Experience event in Frisco, Texas on November 9th,
2013. From November 1-7, the product was available for pre-order sales
and pre-sales exceeded management expectations. Ūth will be
available to the public for purchase later this week on Mannatech.com.
Ūth Skin Rejuvenation Crème releases your body’s natural
ability to support beautiful, healthy skin through a new, patented
microsphere delivery system that nourishes your skin with youth-inducing
ingredients in a time-released pattern. This pattern optimizes the
natural production of skin cells at all levels by delivering naturally
sourced, complex sugars called glycans found in Manapol powder. The
science of glycobiology is uncovering the way our bodies work at the
cellular level. New research in this field has unlocked the knowledge of
why our skin loses youthfulness as we age, and more importantly, how
glycans provide the network that allows cells to communicate and spark
our skin’s natural ability to strengthen itself. The science of
glycobiology has decoded the secrets to healthier, younger-looking skin.
Those discoveries are now available in Mannatech’s new product, Ūth.
Mannatech’s research and development team worked closely with
internationally renowned dermatologist, Dr.
Martin Kassir, to develop Mannatech's Ūth Skin
Rejuvenation Crème. Dr. Kassir utilized his extensive experience and
research to mastermind the formulation in combination with Mannatech’s
advanced glyconutrient technology. Dr. Kassir is double-board certified
in both dermatology and internal medicine and specializes in cosmetic
dermatology and laser procedures. His dermatology practice, in Dallas
and New York City, caters to national and international clientele. Dr.
Kassir has a B.A. from University of Texas at Austin; an M.D. from UT
Southwestern Medical Center in Dallas; and residencies from UT
Southwestern Medical Center (internal medicine), and Kansas University
Medical Center (dermatology), Kansas City. Learn more about Ūth
with these videos: Ūth
Skin Rejuvenation Crème by Mannatech and The
Story of Ūth – Dr. Martin Kassir.
For more information on Mannatech’s products, or to explore its business
opportunity, visit Mannatech.com.
About Mannatech
Mannatech, Incorporated, develops high-quality health, weight and
fitness, and skin care products that are based on the solid foundation
of nutritional science and development standards. Mannatech is dedicated
to its platform of Social Entrepreneurship based on the foundation of
promoting, aiding and optimizing nutrition where it is needed most
around the world. Mannatech’s proprietary products are available through
independent sales Associates around the globe including the United
States, Canada, South Africa, Australia, New Zealand, Austria, Denmark,
Germany, Norway, Sweden, the Netherlands, the United Kingdom, Japan,
Taiwan, Singapore, Estonia, Finland, the Republic of Ireland, Czech
Republic, the Republic of Korea, Mexico, Namibia, Hong Kong and Ukraine.
For more information, visit Mannatech.com.
Please note: This release contains “forward-looking statements”
within the meaning of Section 27A of the Securities Act of 1933, as
amended, Section 21E of the Securities Exchange Act of 1934, as amended,
and the Private Securities Litigation Reform Act of 1995. These
forward-looking statements generally can be identified by use of phrases
or terminology such as “believe,” “intend” or other similar words or the
negative of such terminology. Similarly, descriptions of Mannatech’s
objectives, strategies, plans, goals or targets contained herein are
also considered forward-looking statements. Mannatech believes this
release should be read in conjunction with all of its filings with the
United States Securities and Exchange Commission and cautions its
readers that these forward-looking statements are subject to certain
events, risks, uncertainties and other factors. Some of these factors
include, among others, Mannatech’s inability to attract and retain
Associates and Members, increases in competition, litigation, regulatory
changes and its planned growth into new international markets. Although
Mannatech believes that the expectations, statements and assumptions
reflected in these forward-looking statements are reasonable, it
cautions readers to always consider all of the risk factors and any
other cautionary statements carefully in evaluating each forward-looking
statement in this release, as well as those set forth in its latest
Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other
filings filed with the United States Securities and Exchange Commission,
including its current reports on Form 8-K. All of the forward-looking
statements contained herein speak only as of the date of this release.
Source: Mannatech, Incorporated
Mannatech, Incorporated
Brett Duncan, 972-471-7367
bduncan@mannatech.com